MBX BIOSCIENCES
MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available. It focuses on the discovery, development, and commercialization of first-in-class endocrine therapeutics. The company was founded in 2018 and headquartered in Carmel, Indiana.
MBX BIOSCIENCES
Industry:
Biotechnology Health Care Wellness
Founded:
2019-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.mbxbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
59.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Series A - MBX Biosciences
Twilight Venture Partners
Twilight Venture Partners investment in Series A - MBX Biosciences
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - MBX Biosciences
New Enterprise Associates
New Enterprise Associates investment in Series A - MBX Biosciences
Indiana University Philanthropic Venture Fund
Indiana University Philanthropic Venture Fund investment in Series A - MBX Biosciences
BioCrossroads
BioCrossroads investment in Series A - MBX Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-11 | MBX Biosciences Names CFO |
Official Site Inspections
http://www.mbxbio.com
- Host name: 186.0.153.160.host.secureserver.net
- IP address: 160.153.0.186
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "MBX Biosciences"
Home - MBX Biosciences
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutic candidates to help people with endocrine and …See details»
About Us - MBX Biosciences
By combining deep expertise in peptide discovery and development, MBX Biosciences is pioneering a new era of peptide therapeutics that confront the challenges of managing endocrine and metabolic diseases.See details»
Investors - MBX Biosciences
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutic candidates to help people with endocrine and …See details»
MBX Biosciences, Inc. | LinkedIn
MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPsâ„¢). PEPs are designed to overcome key limitations of native peptide...See details»
MBX Biosciences - PitchBook
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.See details»
MBX Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 (317) 659-0200 MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available.See details»
MBX Biosciences, Inc - BIO International Convention | BIO
Jun 6, 2023 · MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutic candidates to help people with endocrine …See details»
MBX Biosciences – Indiana Health Industry Forum - ihif.org
Nov 20, 2023 · MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide (PEP) therapeutic candidates to help people with endocrine …See details»
MBX Biosciences Closes $115 Million Series B Financing to …
CARMEL, Ind., Nov. 14, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutics …See details»
MBX - app.bpiq.com
MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of …See details»
Our Science - MBX Biosciences
At MBX Biosciences, we are pioneering PEPs to overcome the limitations of native peptide therapeutics. Our intent is to transform the treatment landscape for endocrine and metabolic diseases with efficacious, safe and convenient …See details»
MBX Biosciences to Participate in Upcoming November Investor ...
Oct 28, 2024 · MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEPâ„¢ platform, for …See details»
MBX Stock Price Quote | Morningstar
Nov 21, 2024 · MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of …See details»
MBX Biosciences - Overview, News & Similar companies - ZoomInfo
Aug 18, 2024 · MBX Biosciences contact info: Phone number: (317) 659-0200 Website: www.mbxbio.com What does MBX Biosciences do? MBX Biosciences was founded in 2018, it …See details»
Our Pipeline - MBX Biosciences
At MBX, we are reimagining how patients live with endocrine and metabolic diseases. Enabled by our proprietary PEP TM platform technology, we have a growing pipeline of therapeutic …See details»
Recommended Stories - Yahoo Finance
Aug 7, 2023 · MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutic candidates to help people with endocrine …See details»
MBX Biosciences Raises $63.5 Million in Series C Financing to …
CARMEL, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision …See details»
MBX Biosciences Closes $115 Million Series B Financing to
CARMEL, Ind., Nov. 14, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutics …See details»
MBX Biosciences Closes $34.6 Million Series A Financing in Rare ...
Jul 27, 2020 · MBX Biosciences is a biotechnology company creating therapies for rare endocrine diseases. Members of MBX’s leadership team previously collaborated in the creation of highly …See details»
Careers - MBX Biosciences
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptideâ„¢ (PEPâ„¢) therapeutic candidates to help people with endocrine and …See details»